{"cluster": 45, "subcluster": 7, "abstract_summ": " The COVID -19 pandemic affects anticoagulantion not only for those infected with SARS-CoV-2, but also for most patients who require daily anticoaggulant therapy . Venous thromboembolism (VTE), a potential cause of unexplained deaths, has frequently been reported in COVID-19 cases ."}